6-(2,5-difluoropyridin-3-yloxy)-N-(5-fluoropyridin-2-yl)-[1,2,4]triazolo[1,5-a]pyridine-8-carboxamide

ID: ALA4099750

PubChem CID: 118103959

Max Phase: Preclinical

Molecular Formula: C17H9F3N6O2

Molecular Weight: 386.29

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(Nc1ccc(F)cn1)c1cc(Oc2cc(F)cnc2F)cn2ncnc12

Standard InChI:  InChI=1S/C17H9F3N6O2/c18-9-1-2-14(21-5-9)25-17(27)12-4-11(7-26-16(12)23-8-24-26)28-13-3-10(19)6-22-15(13)20/h1-8H,(H,21,25,27)

Standard InChI Key:  TXVGIMGNEWHENN-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 28 31  0  0  0  0  0  0  0  0999 V2000
   12.8384   -5.1631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2550   -5.9822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2521   -5.1595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5435   -4.7543    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5453   -6.3916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8375   -5.9857    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.2327   -6.5334    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.5667   -7.2779    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3779   -7.1902    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.5411   -3.9371    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.2475   -3.5264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9544   -3.9352    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6604   -3.5252    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.6584   -2.7071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9445   -2.3008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2414   -2.7132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9633   -6.3897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9646   -7.2069    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.6704   -5.9800    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.3787   -6.3875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3754   -7.2031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0829   -7.6105    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7909   -7.2007    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7870   -6.3793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0789   -5.9756    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.4998   -7.6073    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   14.9551   -4.7524    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   14.9391   -1.4837    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  6  1  0
  5  2  1  0
  2  3  2  0
  3  4  1  0
  4  1  2  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  2  0
  4 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
  2 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 23 26  1  0
 12 27  1  0
 15 28  1  0
M  END

Associated Targets(non-human)

Grm5 Metabotropic glutamate receptor 5 (4372 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 386.29Molecular Weight (Monoisotopic): 386.0739AlogP: 2.98#Rotatable Bonds: 4
Polar Surface Area: 94.30Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.23CX Basic pKa: 1.72CX LogP: 2.74CX LogD: 2.74
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.54Np Likeness Score: -1.61

References

1. Felts AS, Rodriguez AL, Morrison RD, Bollinger KA, Venable DF, Blobaum AL, Byers FW, Thompson Gray A, Daniels JS, Niswender CM, Jones CK, Conn PJ, Lindsley CW, Emmitte KA..  (2017)  Discovery of imidazo[1,2-a]-, [1,2,4]triazolo[4,3-a]-, and [1,2,4]triazolo[1,5-a]pyridine-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5.,  27  (21): [PMID:28958625] [10.1016/j.bmcl.2017.09.042]

Source